BMC Surg

1. MATLIM OZEL T, Yilmaz M, Akbulut S, Celik A, et al
   Papillary thyroid carcinoma in graves' disease: prevalence, clinicopathological features, and preoperative predictors.
   BMC Surg. 2026 Feb 17. doi: 10.1186/s12893-026-03602.
   

   >> Share

   
   

   
   Clin Cancer Res

2. LI JZ, Ricarte Filho J, Isaza AR, Hinkle K, et al
   DNA Methylation-based Risk Stratification and Classification of Pediatric Thyroid Carcinoma.
   Clin Cancer Res. 2026 Feb 17. doi: 10.1158/1078-0432.CCR-25-2109.
   

   >> Share

   
   

   
   Diagn Cytopathol

3. HOU T, Mesa H, Puello B, Molden B, et al
   Diagnostic Utility of Ki-67 Index on Cell Block Material for Grading Medullary Thyroid Carcinoma.
   Diagn Cytopathol. 2026 Feb 16. doi: 10.1002/dc.70102.
   

   >> Share

   
   

   
   Eur Thyroid J

4. DUNTAS LH
   The caprices of a trace element: selenium's considerable effects on Hashimoto's thyroiditis, though few on Graves' disease.
   Eur Thyroid J. 2026;15:ETJ260009.
   

   >> Share

   
   
5. CERUTI D, Bonenkamp HJ, Colombo C, Gotthardt M, et al
   Clinical presentation and outcomes of medullary thyroid cancer in two European countries: impact of diagnostic strategies.
   Eur Thyroid J. 2026;15:ETJ250381.
   

   >> Share

   
   
6. SALVI M
   What has changed in thyroid eye disease in the last five years (2020-2025).
   Eur Thyroid J. 2026;15:ETJ250363.
   

   >> Share

   
   
7. URSEM SR, den Elzen WPJ, van den Berg JM, Boelen A, et al
   Natural course of subclinical hyperthyroidism in primary care in the Netherlands.
   Eur Thyroid J. 2025;14:e250142.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

8. MOMO HD, Haymart MR, Shi X, Mondul AM, et al
   Associations Between Radioactive Iodine Treatment for Hyperthyroidism and Cancer Incidence and Mortality.
   J Clin Endocrinol Metab. 2026 Feb 17:dgag058. doi: 10.1210.
   

   >> Share

   
   
9. PATRIZIO A, Mauguen A, Fagin JA, Farooki A, et al
   Exposure to GLP-1RA and risk of structural progression in differentiated thyroid cancer.
   J Clin Endocrinol Metab. 2026 Feb 15:dgag051. doi: 10.1210.
   

   >> Share

   
   
10. TORO-TOBON D
    The Prediction Paradox: AI, Genetics, and Occult Metastasis in Thyroid Cancer.
    J Clin Endocrinol Metab. 2026 Feb 15:dgag065. doi: 10.1210.
    

    >> Share

    
    

    
    Nat Rev Endocrinol

11. DUNTAS LH, Kopp PA
    The long-overlooked effect of hypothyroidism on the global burden of non-communicable diseases.
    Nat Rev Endocrinol. 2026 Feb 16. doi: 10.1038/s41574-026-01235.
    

    >> Share

    
    

    
    Ophthalmic Plast Reconstr Surg

12. ROSENBLATT TR, Chiou CA, Yoon MK, Lee NG, et al
    Extended Long-Term Follow-Up of Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease.
    Ophthalmic Plast Reconstr Surg. 2026 Feb 16. doi: 10.1097/IOP.0000000000003197.
    

    >> Share

    
    

    
    Thyroid

13. HOLLEY M, Razvi S, Maxwell I, Dew R, et al
    Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing UK Population with Subclinical Hypothyroidism: Emulated Target Trial (ACEL-UK-ETT).
    Thyroid. 2026 Feb 19:10507256261426576. doi: 10.1177/10507256261426576.
    

    >> Share

    
    
14. AHN SH, Seo SH, Jung CY, Yu DH, et al
    Long-Term Morbidity after Postoperative Hypoparathyroidism in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study.
    Thyroid. 2026 Feb 18:10507256261425690. doi: 10.1177/10507256261425690.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share